Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined Hyperlipidemia

This publication has 24 references indexed in Scilit:

• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Effect of pravastatin in the prevention of coronary heart disease in patients with primary hypercholesterolemia
  Current Therapeutic Research, 1994
• Combined Treatment with Pravastatin and Gemfibrozil in Patients with Refractory Familial Combined Hyperlipidaemia
  Clinical Drug Investigation, 1994
• Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
  Circulation, 1993
• Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia
  Atherosclerosis, 1993
• Familial lipoprotein disorders in patients with premature coronary artery disease.
  Circulation, 1992
• Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
  Circulation, 1992
• Efficacy and long-term adverse effect pattern of lovastatin
  The American Journal of Cardiology, 1988